138 related articles for article (PubMed ID: 32099329)
1. Development of a Novel Controlled-Release Tablet of Pregabalin: Formulation Variation and Pharmacokinetics in Dogs and Humans.
Kim KH; Lim SH; Shim CR; Park J; Song WH; Kwon MC; Lee JH; Park JS; Choi HG
Drug Des Devel Ther; 2020; 14():445-456. PubMed ID: 32099329
[TBL] [Abstract][Full Text] [Related]
2. Preparation and evaluation of non-effervescent gastroretentive tablets containing pregabalin for once-daily administration and dose proportional pharmacokinetics.
Kim S; Hwang KM; Park YS; Nguyen TT; Park ES
Int J Pharm; 2018 Oct; 550(1-2):160-169. PubMed ID: 30138708
[TBL] [Abstract][Full Text] [Related]
3. Design and optimization of gastro-floating sustained-release tablet of pregabalin: In vitro and in vivo evaluation.
Qin C; Wu M; Xu S; Wang X; Shi W; Dong Y; Yang L; He W; Han X; Yin L
Int J Pharm; 2018 Jul; 545(1-2):37-44. PubMed ID: 29649518
[TBL] [Abstract][Full Text] [Related]
4. Comparative Pharmacokinetics of a Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and an Immediate-release Pregabalin Capsule in Healthy Male Volunteers.
Kim TE; Jeon JY; Gu N; Chang Kwon M; Kim MG
Clin Ther; 2018 Dec; 40(12):2112-2124. PubMed ID: 30497798
[TBL] [Abstract][Full Text] [Related]
5. Formulation of a modified-release pregabalin tablet using hot-melt coating with glyceryl behenate.
Jeong KH; Woo HS; Kim CJ; Lee KH; Jeon JY; Lee SY; Kang JH; Lee S; Choi YW
Int J Pharm; 2015 Nov; 495(1):1-8. PubMed ID: 26315121
[TBL] [Abstract][Full Text] [Related]
6. Pregabalin controlled-release pharmacokinetics in healthy volunteers: analysis of four multiple-dose randomized clinical pharmacology studies.
Chew ML; Alvey CW; Plotka A; Pitman VW; Alebic-Kolbah T; Scavone JM; Bockbrader HN
Clin Drug Investig; 2014 Sep; 34(9):627-37. PubMed ID: 25078977
[TBL] [Abstract][Full Text] [Related]
7. Formulation variation and in vitro-in vivo correlation for a rapidly swellable three-layered tablet of tamsulosin HCl.
Park JS; Shim JY; Park JS; Lee MJ; Kang JM; Lee SH; Kwon MC; Choi YW; Jeong SH
Chem Pharm Bull (Tokyo); 2011; 59(5):529-35. PubMed ID: 21532187
[TBL] [Abstract][Full Text] [Related]
8. A novel three-layered tablet for extended release with various layer formulations and in vitro release profiles.
Park JS; Shim JY; Park JS; Choi YW; Jeong SH
Drug Dev Ind Pharm; 2011 Jun; 37(6):664-72. PubMed ID: 21449708
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
Jantratid E; Prakongpan S; Amidon GL; Dressman JB
Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
11. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
12. Dose-proportional pharmacokinetic properties of GLA5PR GLARS-NF1 controlled-release pregabalin in healthy Korean volunteers: a randomized, open, single-dose, parallel study.
Shin KH; Jeon JY; Jang K; Kim TE; Kim MG
Drug Des Devel Ther; 2018; 12():3449-3457. PubMed ID: 30349198
[TBL] [Abstract][Full Text] [Related]
13. A Three-Pulse Release Tablet for Amoxicillin: Preparation, Pharmacokinetic Study and Physiologically Based Pharmacokinetic Modeling.
Li J; Chai H; Li Y; Chai X; Zhao Y; Zhao Y; Tao T; Xiang X
PLoS One; 2016; 11(8):e0160260. PubMed ID: 27479702
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of the controlled-release nisoldipine coat-core tablet formulation.
Heinig R; Ahr G; Hayauchi Y; Kuhlmann J
Int J Clin Pharmacol Ther; 1997 Aug; 35(8):341-51. PubMed ID: 9266290
[TBL] [Abstract][Full Text] [Related]
15. Modulation of microenvironmental pH for dual release and reduced in vivo gastrointestinal bleeding of aceclofenac using hydroxypropyl methylcellulose-based bilayered matrix tablet.
Kang WH; Nguyen HV; Park C; Choi YW; Lee BJ
Eur J Pharm Sci; 2017 May; 102():85-93. PubMed ID: 28263912
[TBL] [Abstract][Full Text] [Related]
16. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of hydrocodone extended-release tablets formulated with different levels of coating to achieve abuse deterrence compared with a hydrocodone immediate-release/acetaminophen tablet in healthy subjects.
Darwish M; Bond M; Tracewell W; Robertson P; Yang R
Clin Drug Investig; 2015 Jan; 35(1):13-22. PubMed ID: 25391549
[TBL] [Abstract][Full Text] [Related]
18. A design and evaluation of layered matrix tablet formulations of metoprolol tartrate.
Baloğlu E; Senyiğit T
AAPS PharmSciTech; 2010 Jun; 11(2):563-73. PubMed ID: 20352535
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of pregabalin controlled-release in healthy volunteers: effect of food in five single-dose, randomized, clinical pharmacology studies.
Chew ML; Plotka A; Alvey CW; Pitman VW; Alebic-Kolbah T; Scavone JM; Bockbrader HN
Clin Drug Investig; 2014 Sep; 34(9):617-26. PubMed ID: 25078976
[TBL] [Abstract][Full Text] [Related]
20. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
